Morgan Stanley’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$489K Sell
169,038
-242,342
-59% -$700K ﹤0.01% 5467
2025
Q1
$884K Buy
411,380
+241,201
+142% +$519K ﹤0.01% 5059
2024
Q4
$659K Buy
170,179
+20,951
+14% +$81.1K ﹤0.01% 5304
2024
Q3
$977K Buy
149,228
+95,615
+178% +$626K ﹤0.01% 5051
2024
Q2
$389K Buy
53,613
+6,324
+13% +$45.8K ﹤0.01% 5403
2024
Q1
$359K Sell
47,289
-65,139
-58% -$494K ﹤0.01% 5465
2023
Q4
$512K Buy
112,428
+88,094
+362% +$401K ﹤0.01% 5605
2023
Q3
$96.1K Sell
24,334
-8,052
-25% -$31.8K ﹤0.01% 5911
2023
Q2
$101K Sell
32,386
-32,002
-50% -$100K ﹤0.01% 5947
2023
Q1
$292K Sell
64,388
-476,449
-88% -$2.16M ﹤0.01% 5526
2022
Q4
$2.23M Buy
540,837
+10,544
+2% +$43.5K ﹤0.01% 4382
2022
Q3
$1.7M Buy
530,293
+485
+0.1% +$1.55K ﹤0.01% 4544
2022
Q2
$1.04M Sell
529,808
-176
-0% -$345 ﹤0.01% 4997
2022
Q1
$2.15M Buy
529,984
+518,189
+4,393% +$2.1M ﹤0.01% 4471
2021
Q4
$127K Sell
11,795
-23,265
-66% -$251K ﹤0.01% 6298
2021
Q3
$404K Buy
35,060
+472
+1% +$5.44K ﹤0.01% 5626
2021
Q2
$339K Buy
34,588
+8,471
+32% +$83K ﹤0.01% 5742
2021
Q1
$382K Sell
26,117
-6,938
-21% -$101K ﹤0.01% 5307
2020
Q4
$708K Sell
33,055
-20,745
-39% -$444K ﹤0.01% 4859
2020
Q3
$816K Buy
53,800
+18,112
+51% +$275K ﹤0.01% 4354
2020
Q2
$459K Sell
35,688
-105,579
-75% -$1.36M ﹤0.01% 4644
2020
Q1
$1.31M Sell
141,267
-446
-0.3% -$4.12K ﹤0.01% 3736
2019
Q4
$1.89M Sell
141,713
-1,966
-1% -$26.2K ﹤0.01% 4087
2019
Q3
$1.27M Buy
143,679
+128,295
+834% +$1.14M ﹤0.01% 4139
2019
Q2
$220K Buy
15,384
+9,249
+151% +$132K ﹤0.01% 4983
2019
Q1
$202K Sell
6,135
-14,250
-70% -$469K ﹤0.01% 5055
2018
Q4
$1.21M Buy
20,385
+16,192
+386% +$962K ﹤0.01% 4137
2018
Q3
$589K Buy
4,193
+55
+1% +$7.73K ﹤0.01% 4903
2018
Q2
$508K Buy
4,138
+1,465
+55% +$180K ﹤0.01% 5090
2018
Q1
$238K Buy
2,673
+2,343
+710% +$209K ﹤0.01% 5398
2017
Q4
$18K Buy
330
+223
+208% +$12.2K ﹤0.01% 6103
2017
Q3
$5K Sell
107
-3,188
-97% -$149K ﹤0.01% 6292
2017
Q2
$139K Buy
3,295
+40
+1% +$1.69K ﹤0.01% 5499
2017
Q1
$182K Sell
3,255
-5,309
-62% -$297K ﹤0.01% 5364
2016
Q4
$327K Buy
8,564
+5,858
+216% +$224K ﹤0.01% 5148
2016
Q3
$107K Sell
2,706
-6,604
-71% -$261K ﹤0.01% 5277
2016
Q2
$670K Buy
9,310
+2,981
+47% +$215K ﹤0.01% 4262
2016
Q1
$507K Sell
6,329
-3,856
-38% -$309K ﹤0.01% 4435
2015
Q4
$768K Buy
10,185
+6,360
+166% +$480K ﹤0.01% 4240
2015
Q3
$1.47M Buy
3,825
+2,361
+161% +$906K ﹤0.01% 3786
2015
Q2
$608K Buy
1,464
+858
+142% +$356K ﹤0.01% 4574
2015
Q1
$288K Buy
606
+507
+512% +$241K ﹤0.01% 5002
2014
Q4
$37K Sell
99
-5,123
-98% -$1.91M ﹤0.01% 5894
2014
Q3
$1.23M Buy
+5,222
New +$1.23M ﹤0.01% 3865